Skip to main content
$1.27 $0.05 (4.1%)

04:00 PM EST on 11/29/23

Esperion Therapeutics (NASDAQ:ESPR)

CAPS Rating: 5 out of 5

Current Price $1.27 Mkt Cap $144.4M
Open $1.22 P/E Ratio -0.54
Prev. Close $1.27 Div. (Yield) $0.00 (0.0%)
Daily Range $1.19 - $1.29 Volume 4,004,635
52-Wk Range $0.70 - $8.87 Avg. Daily Vol. 3,827,151

Caps

How do you think NASDAQ:ESPR will perform against the market?

Add Stock to CAPS Watchlist

All Players

57 Outperform
10 Underperform
 

All-Star Players

9 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ESPR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

solmyr45 (66.99)
Submitted January 03, 2020

ESPR is all in on bempedoic acid, which reduces LDL-C cholesterol in statin-resistant/intolerant patients (meaning folks who have intolerable side effects from Lipitor). Massive potential given market size. IPO 2013 at $17. Broke $105 in '15, sunk to… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about ESPR.

Recs

0
Member Avatar pmatthews987 (< 20) Submitted: 9/23/2021 7:35:58 PM : Outperform Start Price: $11.82 NASDAQ:ESPR Score: -92.24

LDL lowering pills

Recs

0
Member Avatar lfgonza (< 20) Submitted: 11/13/2020 2:50:37 PM : Outperform Start Price: $28.52 NASDAQ:ESPR Score: -122.77

Technical analysis (Elliot Wave and Fibonachi) supports the upside potential.

Recs

0
Member Avatar screach (79.61) Submitted: 4/4/2020 1:21:14 PM : Outperform Start Price: $32.05 NASDAQ:ESPR Score: -172.35

blockbuster drug approval not reflected in stock price. What's not to like?

Leaderboard

Find the members with the highest scoring picks in ESPR.

Score Leader

TerryHoodSr

TerryHoodSr (47.98) Score: +648.65

The Score Leader is the player with the highest score across all their picks in ESPR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Hendrickson71 < 20 9/30/2015 Underperform NS $21.86 -94.19% +137.93% +232.12 1 Comment
mangotime 36.29 3/26/2015 Underperform 5Y $85.33 -98.51% +121.80% +220.32 0 Comment
joe508mama 29.70 3/17/2015 Underperform 5Y $88.63 -98.57% +119.31% +217.88 0 Comment
kevinshaw98 35.44 3/25/2015 Underperform 3W $94.20 -98.65% +118.31% +216.96 0 Comment
GuruGrowth 47.45 3/25/2015 Underperform 5Y $102.74 -98.76% +117.44% +216.21 0 Comment
Avi12 57.01 3/23/2015 7/8/2017 Underperform 3Y $109.73 -98.84% +115.79% +214.63 0 Comment
AntMan56 49.43 3/23/2015 Underperform 5Y $109.73 -98.84% +115.79% +214.63 0 Comment
cclark04 43.63 3/23/2015 Underperform 3M $109.73 -98.84% +115.79% +214.63 0 Comment
WildShaman 78.39 7/9/2018 Underperform 5Y $44.59 -97.15% +64.39% +161.54 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MarkBiotech < 20 8/21/2018 Underperform 5Y $49.31 -97.42% +58.56% +155.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ESPR.